Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response

Respiration

Volumn 71, Issue 3, 2004, Pages 216-224

  Boulay, Marie Eve ^a   Prince, Philippe ^a   Deschesnes, Francine ^a   Chakir, Jamila ^a   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Allergen challenge; Asthma; Induced sputum; Late asthmatic response; MMP 9

Indexed keywords

ALLERGEN; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ALLERGIC ASTHMA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPUTUM ANALYSIS; SPUTUM SMEAR;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; SEVERITY OF ILLNESS INDEX; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 2342542871     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077418     Document Type: Article

References (42)

1. Björnsdottir US, Cypcar DM: Asthma: An inflammatory mediator soup. Allergy 1999;54:55-61.
2. Boulet LP, Chakir J, Dubé J: Airway inflammation and structural changes in airway hyperresponsiveness and asthma: An overview. Can Respir J 1998;5:16-21.
3. Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, Holgate ST, Howarth PH: Basic fibroblast growth factor in asthma: Measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384-387.
4. Busse WW, Calhoun WJ, Sedgwick JB: Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993;147:S20-S24.
5. de Monchy JGR, Kauffman HF, Venge P: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-376.
6. Frew AJ, Kay AB: Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin Immunol 1990;85:533-539.
7. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389.
8. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F: Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-591.
9. Mautino G, Henriquet C, Gougat C, Le Cam A, Dayer JM, Capony F: Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest 1999;79:39-47.
10. Lemjabbar H, Gosset P, Lamblin C, Tillie I, Hartmann D, Wallaert B, Tonnel AB, Lafuma C: Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999;159:1298-1307.
11. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamauchi K, Nagura H, Shirato K: Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-219.
12. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S: Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 2000;105:900-905.
13. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Okada Y: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000;59:455-461.
14. Hoshino M, Nakamura Y, Sim JJ, Shimojo J, Isogai S: Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-788.
15. Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999;160:725-729.
16. Shapiro SD, Senior RM: Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-1102.
17. Dahlen B, Shute J, Howarth P: Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999;54:590-596.
18. Mautino G, Henriquet C, Jaffuel D, Bousquet J, Capony F: Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 1999;160:324-330.
19. Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, Mautino G, D'Accardi P, Bousquet J, Bonsignore G: Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998;158:1945-1950.
20. Bossé M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M: Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999;159:596-602.
21. Kelly EA, Busse WW, Jarjour NN: Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162:1157-1161.
22. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
23. ATS statement. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987;136: 1285-1298.
24. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B: Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
25. Juniper EF, Cockcroft DW, Hargreave FE: Histamine and methacholine inhalation test: A laboratory tidal breathing protocol. Astra Draco AB 1994;1-49.
26. Cockcroft DW, Murdock KY, Kirby J, Hargreave F: Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987;135:264-267.
27. Boulay ME, Boulet LP: Lower airway inflammatory responses to repeated very-low-dose allergen challenge in allergic rhinitis and asthma. Clin Exp Allergy 2002;32:1441-1447.
28. Cataldo DD, Bettiol J, Noel A, Bartsch P, Foidart JM, Louis R: Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002;122:1553-1559.
29. Pizzichini E, Pizzichini MMM, Kidney JC, Efthimiadis A, Hussack P, Popov T, Cox G, Dolovich J, O'Byrne P, Hargreave FE: Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: Inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J 1998;11:828-834.
30. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ: Cellular profiles in asthmatic airways: A comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997;52:372-374.
31. Maestrelli P, Saetta M, Di Stefano A, Calcagni PG, Turato G, Ruggieri MP, Roggeri A, Mapp CE, Fabbri LM: Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995;152:1926-1931.
32. Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW: Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993;147:1465-1471.
33. Vignola AM, Chanez P, Chiappara G, Merendino AM, Pace E, Rizzo A, La Rocca AM, Bellia V: Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996;106:114-119.
34. Fujisawa T, Kato Y, Terada A, Iguchi K, Kamiya H: Matrix metalloproteinase-9 in peripheral blood eosinophils. Int Arch Allergy Immunol 1999;120:65-69.
35. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996;14:288-295.
36. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G: Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681.
37. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-1539.
38. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ: Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
39. O'Byrne PM, Postma DS: The many faces of airway inflammation. Am J Respir Crit Care Med 1999;159:S41-S66.
40. Busse WW, Lemanske RF: Review articles: Advances in Immunology: Asthma. N Engl J Med 2001;344:350-362.
41. Hayakawa T: Tissue inhibitors of metalloproteinases and their cell growth-promoting activity. Cell Struct Funct 1994;19:109-114.
42. Chakir J, Laviolette M, Boutet M, Laliberté R, Dubé J, Boulet LP: Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-744.